Abstract
Glucagon has been prescribed routinely on diagnosis of paediatric type 1 diabetes. A forum of paediatric diabetes specialist nurses sought to examine whether this practice is evidence based. Forum members audited their own caseloads, including the families and carers, their professional practices and those of other teams nationally. It was found that the prescription of glucagon varies and its use is often limited by lack of confidence. They found little evidence to support routine prescription on diagnosis and recommend that individual case assessment of risk and of the needs and preferences of families and carers would be more cost effective. Families and carers who do acquire a glucagon injection kit should receive regular training in its use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
